Publicaciones en colaboración con investigadores/as de Mutua de Terrassa (4)

2023

  1. Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

    Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901

2015

  1. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

    Current Medical Research and Opinion, Vol. 31, Núm. 6, pp. 1129-1137

2011

  1. Spanish multi-centre observational study of the first attacks suggestive of multiple sclerosis: The PREM cohort

    Revista de Neurologia, Vol. 53, Núm. 10, pp. 577-583

2004

  1. Corticosteroids, ibuprofen, and acetaminophen for IFNβ-1a flu symptoms in MS: A randomized trial

    Neurology, Vol. 63, Núm. 3, pp. 525-528